Jazz Pharmaceuticals
, Nasdaq: JAZZDeveloping treatments for various neurological and psychiatric disorders.
Industry: Health Care
First Day Return: -1.5%
JAZZ
Developing treatments for various neurological and psychiatric disorders.
| IPO Date | 05/31/2007 |
|---|---|
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $108 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| IPO Intelligence Only |
| Headquarters | Palo Alto, CA, United States |
|---|---|
| Founded | 2003 |
| Employees at IPO | 407 |
| Website www.jazzpharmaceuticals.com | |
IPO News for Jazz Pharmaceuticals
Jazz Pharmaceuticals (JAZZ) Performance
